MIR4698

Across TCGA pan-cancer cohorts, MIR4698 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR4698 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher MIR4698 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4698 expression acts as an unfavorable survival marker, although some lineages such as LUAD and ESCA show a favorable association.

PAAD, LUSC, and LUAD are the cancer types where MIR4698 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.238	0.542	.001	72	view →
LUSC	OS	Tertile	III,IV	0.248	0.677	.002	54	view →
LUAD	OS	Tertile	II,III,IV	0.944	0.712	.013	45	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
LIHC	OS	Tertile	II,III,IV	0.205	0.718	<.001	36	view →
TGCT	OS	Tertile	All	0.083	0.969	<.001	36	view →
ESCA	OS	Median	III,IV	0.573	0.311	.003	30	view →
BLCA	OS	Tertile	IV	0.790	0.546	.007	30	view →
GBM	DFS	Tertile	All	0.071	0.288	.009	18	view →
THYM	DFS	Tertile	All	0.698	0.911	.028	15	view →
THCA	OS	Tertile	IV	0.720	1.000	.004	15	view →
STAD	DFS	Quartile	All	0.281	0.483	.011	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR4698–PAAD (DFS)

Open the PAAD breakdown →